Coronary artery disease develops through a chain of biological events that begins decades before a person ever feels chest pain. It starts with damage to the inner lining of the heart’s arteries, progresses through a slow buildup of cholesterol-laden plaques, and can end with a sudden clot that blocks blood flow to the heart muscle. What makes the disease so dangerous is that many of these steps are silent, and the artery can compensate for growing plaques long enough to mask the problem until it becomes severe.
Where It Begins: Damage to the Artery Lining
The innermost layer of every artery is a single-cell-thick lining called the endothelium. In a healthy state, it controls how much the artery dilates or constricts, repels blood clots, and regulates which molecules pass from the bloodstream into the vessel wall. When this lining is damaged or dysfunctional, the artery loses those protective abilities, and the conditions for plaque formation are set.
What damages the endothelium? The usual suspects are high blood pressure, smoking, high blood sugar, and chronically elevated cholesterol. But the physical forces of blood flow matter too. At bends and branch points in the coronary arteries, blood flow is turbulent rather than smooth, creating low shear stress on the vessel wall. Research has shown that segments of coronary arteries exposed to low shear stress are far more likely to develop severe endothelial dysfunction. In one study, about 70% of low-shear-stress segments had severe dysfunction, compared to roughly a fifth of segments with higher shear stress. No segment with normal endothelial function had low shear stress. After adjusting for other risk factors, low shear stress carried roughly nine-fold odds of severe endothelial dysfunction, with diabetes and female sex also emerging as independent predictors.1PubMed Central. Low Coronary Wall Shear Stress is Associated with Severe Endothelial Dysfunction in Patients with Non-Obstructive Coronary Artery Disease This helps explain why plaques tend to cluster at specific locations in the coronary tree rather than coating arteries uniformly.
Cholesterol Gets Trapped in the Wall
Once the endothelium is compromised, low-density lipoprotein particles, the main carriers of cholesterol in the blood, can slip into the artery wall. Getting in is the easy part. Staying there is what makes them dangerous. LDL particles bind to molecules called proteoglycans in the tissue beneath the endothelium. The binding is electrostatic: positively charged regions on the LDL surface latch onto negatively charged chains on the proteoglycans.2PubMed Central. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel This retention is not incidental. Genetic experiments that alter either the binding site on LDL or the matching site on the proteoglycans dramatically reduce plaque formation, confirming that trapping LDL in the wall is a critical step.3PubMed. Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis
Once stuck, LDL particles undergo chemical changes. Cells in the artery wall oxidize the trapped LDL, turning it into a modified form that the immune system recognizes as foreign.4PubMed. Lipid retention in the arterial wall of two mouse strains with different atherosclerosis susceptibility This modified LDL triggers an inflammatory alarm, drawing white blood cells into the wall and launching the immune response that will, ironically, make the disease worse.
Immune Cells Move In and Become Foam Cells
The inflammatory signal from oxidized LDL attracts monocytes, a type of white blood cell, out of the bloodstream and into the artery wall. Once there, monocytes mature into macrophages, which act as the immune system’s cleanup crew. Their job is to eat the oxidized LDL. But the process goes wrong: macrophages gorge on so much modified cholesterol that they swell into what pathologists call foam cells, named for the foamy appearance of all those fat droplets under a microscope.
Macrophages take up oxidized LDL through surface receptors called scavenger receptors, particularly CD36 and SRA. Unlike the normal LDL receptor, scavenger receptors are not downregulated when the cell is full of cholesterol, so the macrophage keeps eating until it is engorged. Research has identified mechanisms that can prevent or reverse this. Activating a specific integrin on macrophages persistently shuts down CD36 and SRA expression and can even reverse the uptake of oxidized LDL in cells that have already become fully loaded foam cells.5The American Journal of Pathology. Ligation of αVβ3 Integrin on Blood Monocytes and Macrophages Prevents Differentiation into Foam Cells and Down-Regulates Scavenger Receptors That finding is promising, but in real disease, foam cells accumulate relentlessly, and their eventual death contributes to the growing plaque.
Smooth Muscle Cells Switch Roles
Arteries are not just passive tubes. The muscular middle layer of the artery wall contains smooth muscle cells that normally contract and relax to regulate blood flow. In atherosclerosis, these cells undergo a dramatic identity shift. They downregulate the proteins that allow them to contract and switch into a more mobile, proliferative state, migrating into the growing plaque.6PubMed Central. Vascular smooth muscle cell phenotypic switching in atherosclerosis
This phenotypic switching is a double-edged sword. On one hand, smooth muscle cells that migrate into the plaque produce structural proteins and help form a fibrous cap over the plaque’s core, which stabilizes it. On the other hand, these transformed cells also secrete enzymes that can break down the surrounding tissue and contribute to plaque remodeling in ways that make it more dangerous.7PubMed Central. Phenotypic Switching of Vascular Smooth Muscle Cells in Atherosclerosis Whether smooth muscle cell involvement stabilizes or destabilizes a given plaque depends on context, and researchers are still working out the details.
The Necrotic Core and Failed Cleanup
As foam cells die, their contents spill into the artery wall, creating a lipid-rich zone called the necrotic core. In most tissues, dead cells are rapidly cleared by a process called efferocytosis, where neighboring macrophages engulf and digest cellular debris. In atherosclerotic plaques, this cleanup system is broken.
The failure of efferocytosis is a major and underappreciated driver of plaque growth. Dead cells that should be cleared within hours instead accumulate for weeks, releasing toxic contents that kill neighboring cells and expand the necrotic core further. Research has shown that this breakdown is caused by dysregulation of “eat me” signals, the molecular flags that dying cells display so that macrophages can find and consume them. Restoring efferocytosis in experimental models slows plaque progression, suggesting the defect is reversible in principle.8PubMed Central. The Role of Efferocytosis in Atherosclerosis The size of the necrotic core is one of the strongest predictors of whether a plaque will eventually rupture.
Inflammation as an Accelerant
Every step described so far involves inflammation, but certain molecular amplifiers make the cycle especially vicious. One key player is the NLRP3 inflammasome, a protein complex inside immune cells that, when activated, triggers the release of powerful inflammatory signals. Platelets, the small blood cells best known for clotting, also express NLRP3, and platelet NLRP3 levels are markedly higher in people with acute coronary syndromes compared to those with stable disease, which are in turn higher than in people with normal coronary arteries. Higher platelet NLRP3 levels correlate with higher circulating levels of the inflammatory cytokines interleukin-1β and interleukin-18.9Cardiology Plus. Enhanced platelet NLRP3 inflammasome expression in patients with acute coronary syndrome and stable coronary artery disease: A prospective observational study This is not just a bystander observation: clinical trials targeting this inflammatory pathway (the CANTOS trial, for instance) have shown that blocking interleukin-1β reduces heart attacks independent of cholesterol levels, confirming that inflammation is a causal force in the disease.
When Plaques Become Dangerous
Most coronary plaques never cause a heart attack. The ones that do typically share a specific anatomy: a large necrotic core covered by a thin fibrous cap. When that cap ruptures, it exposes the plaque’s interior to flowing blood, triggering an immediate clot that can block the artery entirely.
Cap thinning is driven largely by enzymes called matrix metalloproteinases (MMPs) that chew through the structural proteins holding the cap together. Patients with thin-cap plaques have roughly twice the plasma levels of MMP-9 compared to those without, and MMP-9 levels are negatively correlated with fibrous cap thickness.10PubMed. Close Association of Matrix Metalloproteinase-9 Levels With the Presence of Thin-Cap Fibroatheroma in Acute Coronary Syndrome Patients Gene expression studies of ruptured plaques confirm this picture: they show simultaneous overexpression of multiple MMPs targeting collagens, elastins, and other structural proteins, combined with a loss of smooth muscle cells that would normally maintain the cap.11PubMed Central. A pro-inflammatory and fibrous cap thinning transcriptome profile accompanies carotid plaque rupture leading to stroke
Not all heart attacks come from ruptured plaques, though. A substantial fraction, perhaps a third or more, result from plaque erosion, where the endothelial surface over a plaque is stripped away without the cap tearing open. In this scenario, blood clot formation is triggered at the exposed surface. Neutrophil extracellular traps, web-like structures released by a type of white blood cell, provide a scaffold for platelets and clotting factors and enhance coagulation through multiple pathways simultaneously.12PubMed Central. Neutrophil Extracellular Traps: Villains and Targets in Arterial, Venous, and Cancer-Associated Thrombosis Once a clot begins forming, tissue factor, a protein expressed abundantly in macrophages and smooth muscle cells within the plaque, activates the coagulation cascade, leading to fibrin deposition and further platelet activation.13PubMed. Role of tissue factor in hemostasis, thrombosis, and vascular development14PubMed. Tissue factor-driven thrombin generation and inflammation in atherosclerosis
How Arteries Hide the Problem
One reason coronary artery disease can remain invisible for so long is that arteries compensate for growing plaques by expanding outward rather than letting the plaque encroach on the blood channel. This is called positive remodeling, and it was first described in a landmark study showing that coronary arteries enlarge in proportion to plaque size. Functionally significant narrowing of the artery may not occur until the plaque occupies about 40% of the area inside the elastic boundary of the vessel wall.15PubMed. Compensatory enlargement of human atherosclerotic coronary arteries
Positive remodeling sounds helpful, and in the short term it is. But outward-expanding plaques are actually more likely to be the vulnerable type. They tend to have larger necrotic cores, more inflammation, and thinner caps than plaques that grow inward and cause gradual narrowing.16PubMed Central. Whys and Wherefores of Coronary Arterial Positive Remodeling Segments with more healthy wall remaining at baseline are more prone to undergo positive remodeling over subsequent years.17Atherosclerosis. Positive remodeling at 3 year follow up is associated with plaque free coronary wall segment at baseline: A serial IVUS study The clinical paradox is real: plaques that cause the least noticeable narrowing on a standard angiogram can be the most dangerous.
The Role of Calcification
As plaques mature, calcium deposits often form within them, which is why coronary calcium scoring on a CT scan can predict heart disease. The relationship between calcification and plaque stability is more nuanced than it might seem. Large, dense sheets of calcium tend to stabilize a plaque, effectively acting as armor. But small, scattered spots of calcium, called microcalcifications, can concentrate mechanical stress and potentially increase the risk of cap rupture. Fatigue-life modeling of plaques has shown that roughly 84% of calcified configurations actually increase the plaque’s resistance to rupture, with the benefit being greatest when the calcium sits close to the inner surface of the artery rather than near the lipid pool.18PubMed Central. How Does Calcification Influence Plaque Vulnerability? Insights from Fatigue Analysis So a heavily calcified artery is not necessarily on the verge of disaster. The pattern and location of the calcium matter more than the amount.
Beyond the Large Arteries: Microvascular Disease
Not all coronary artery disease involves blockages you can see on an angiogram. Coronary microvascular dysfunction affects the tiny vessels that actually deliver blood to heart muscle cells. When these vessels cannot dilate properly under stress, the heart muscle is starved of oxygen even though the large arteries appear open. This condition, increasingly recognized as a cause of ischemia with nonobstructive coronary arteries, or INOCA, is diagnosed through specialized invasive testing of coronary artery function.19PubMed Central. Coronary Microvascular Dysfunction in Ischemia With Nonobstructive Coronary Arteries and Associations With Sublingual Microvascular Abnormalities
The causes of microvascular dysfunction overlap with those of large-vessel disease. Endothelial dysfunction, inflammation, and oxidative stress all play roles.20PubMed. Microvascular Dysfunction in Ischemia with No Obstructive Coronary Arteries (INOCA): Pathophysiology, Diagnosis, and Emerging Therapies In some patients, microvascular spasm can restrict blood flow even at rest.21PubMed Central. INOCA/ANOCA: Mechanisms and novel treatments This is an area where the old model of coronary disease, one focused entirely on large blockages, falls short. Many patients who were historically told “your arteries are clear” actually have disease at the microvascular level.
What Happens When Blood Flow Returns
When a coronary artery is blocked and then reopened, whether by clot-dissolving drugs or a stent, the restored blood flow is lifesaving but also paradoxically harmful. This is reperfusion injury. During the period of oxygen deprivation, conditions inside heart muscle cells shift: calcium accumulates, fatty acids build up, and reactive oxygen species rise. These changes prime a critical structure in the cell’s mitochondria, the mitochondrial permeability transition pore.22PubMed. Role of the mitochondrial permeability transition in myocardial disease
When blood flow resumes and oxygen floods back in, this pore opens wide, allowing molecules to pour across the inner mitochondrial membrane in an uncontrolled fashion. The result is mitochondrial collapse and cell death through both orderly and chaotic pathways.23PubMed Central. The mitochondrial permeability transition pore and ischemia-reperfusion injury The opening of this pore in the first few minutes of reperfusion may account for up to half of the final heart attack size, meaning that a substantial portion of tissue death happens not during the blockage but after the artery is reopened.24PubMed. The mitochondrial permeability transition pore and its role in myocardial ischemia reperfusion injury Experimental drugs that block this pore at the moment of reperfusion have shown the ability to reduce damage in both lab and clinical settings, though translating this into standard treatment has proved difficult.
Diabetes, Glycation, and Accelerated Disease
People with diabetes develop coronary artery disease earlier, faster, and more severely than those without it. One reason beyond the obvious metabolic derangements is a chemical process called glycation. When blood sugar is persistently high, glucose molecules react with proteins throughout the body, forming compounds known as advanced glycation end products, or AGEs. These accumulate in the artery wall, where they cross-link structural proteins and stiffen the vessel, alter how immune cells behave, and directly promote inflammation.25PubMed Central. Role of advanced glycation end products in cardiovascular disease
AGEs also bind to specific receptors on cells within the artery wall, triggering inflammatory signaling cascades that accelerate plaque formation. Epidemiologic and imaging studies suggest that circulating AGE levels correlate with both the extent of atherosclerosis and the risk of future cardiovascular events in certain populations.26Cardiology in Review. Advanced glycation end products and diabetic cardiovascular disease This pathway helps explain why tight blood sugar control matters not just for preventing nerve and kidney damage, but for slowing the progression of coronary disease.
Fat Around the Arteries
The coronary arteries sit embedded in a layer of fat called perivascular adipose tissue. For a long time, this fat was assumed to be inert padding. It is not. Perivascular fat is metabolically active and secretes a variety of signaling molecules that directly affect the underlying artery, influencing vascular tone, inflammation, and the progression of plaques.27PubMed Central. Perivascular adipose tissue and coronary vascular disease The relationship runs both directions: inflammation within the artery wall sends signals back into the surrounding fat, causing it to shrink and change composition in ways that can be detected on CT scans.28PubMed Central. Perivascular Fat: A Novel Risk Factor for Coronary Artery Disease Measuring these changes in perivascular fat is emerging as a potential way to detect inflamed, high-risk plaques noninvasively.
The Gut Connection
An unexpected contributor to coronary disease comes from the gut. When you eat foods rich in certain nutrients found in red meat and eggs, such as choline, carnitine, and phosphatidylcholine, gut bacteria ferment them into a precursor molecule, which the liver then converts into trimethylamine N-oxide, or TMAO. Elevated TMAO levels promote atherosclerosis by increasing vascular inflammation, impairing the normal function of the blood vessel lining, and disrupting cholesterol metabolism at multiple levels.29Current Research in Nutrition and Food Science Journal. A Review of The Contribution of Gut-Dependent Microbiota Derived Marker, Trimethylamine N-oxide (TMAO), in Coronary Artery Disease The composition of your gut microbiome influences how much TMAO you produce from the same meal, which may partly explain why two people with similar diets can have very different cardiovascular risk.
Clonal Hematopoiesis: A Newly Recognized Risk Factor
One of the most surprising discoveries in cardiovascular science over the past decade is the link between age-related mutations in blood-forming stem cells and coronary artery disease. As people age, some stem cells in the bone marrow acquire random mutations and expand into dominant clones, a phenomenon called clonal hematopoiesis of indeterminate potential, or CHIP. Even though these mutations are not cancerous, they profoundly affect the immune cells those stem cells produce.
Carriers of CHIP mutations have roughly double the risk of coronary heart disease compared to non-carriers. In people who developed heart attacks at a young age, CHIP was associated with a fourfold increase in risk. The mutations most strongly linked to heart disease involve genes like TET2, DNMT3A, ASXL1, and JAK2. In mouse experiments, knocking out TET2 in bone marrow cells led to larger atherosclerotic plaques and overexpression of inflammatory genes in macrophages.30PubMed Central. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease In people with established coronary disease, carrying CHIP mutations predicts worse long-term outcomes, with especially high risk seen in TET2 carriers.31PubMed Central. Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease Invasive imaging has revealed that TET2 carriers are particularly prone to blockages in the left main and left anterior descending arteries, locations where disease is most consequential.32PubMed Central. Invasive Assessment of Coronary Artery Disease in Clonal Hematopoiesis of Indeterminate Potential
An Evolutionary Vulnerability
Humans are unusually prone to atherosclerosis compared to other large mammals, and the explanation may partly lie in our evolutionary history. Millions of years ago, the human lineage lost the ability to produce a sugar molecule called Neu5Gc that coats cells in virtually all other mammals. We still absorb small amounts of Neu5Gc from dietary red meat, and because our immune system recognizes it as foreign, we generate antibodies against it. In mice engineered to mimic this human-specific genetic loss, feeding a Neu5Gc-rich diet while eliciting anti-Neu5Gc antibodies led to significantly more atherosclerosis than in control animals on the same high-fat diet without the antibody response.33PubMed Central. Dietary Neu5Ac Intervention Protects Against Atherosclerosis Associated With Human-Like Neu5Gc Loss-Brief Report This is a genuinely unique piece of human biology, a low-grade inflammatory reaction to a molecule in red meat that most other species simply produce themselves. It suggests that at least part of the association between red meat consumption and cardiovascular disease could operate through an immune pathway specific to our species.